Press Release

Sensus Healthcare Announces Strategic Agreement with SkinCure Oncology

BOCA RATON, Fla., July 12, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation Therapy (IGSRT), today announced a strategic agreement focused on marketing the SRT-100 Vision™ with SkinCure Oncology, a leading turnkey provider of IGSRT solutions in the dermatology industry. […]

Read More

Sensus Healthcare to Join Russell Microcap® Index

BOCA RATON, Fla., June 25, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that it is set to join the Russell Microcap® Index at the conclusion of the Russell U.S. Indexes annual reconstitution, effective before the U.S. market […]

Read More

Sensus Healthcare to Participate in Panel Discussion at the Cantor Fitzgerald Dermatology & Aesthetics Summit

BOCA RATON, Fla., June 12, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS),a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that Joe Sardano, Chairman and Chief Executive Officer of Sensus Healthcare, will participate in a panel discussion, titled “New Treatments for Rare/Orphan Diseases and Oncologic Conditions,” at […]

Read More

Sensus Healthcare to Present at the 8th Annual LD Micro Invitational

LOS ANGELES, CA / ACCESSWIRE / May 29, 2018 / Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that it will be presenting at the 8th Annual LD Micro Invitational on Tuesday, June 5 at 2:30pm PST/5:30pm […]

Read More

Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development

BOCA RATON, Fla. (May 8, 2018) – Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced the appointment of Dr. Isabelle Raymond, PhD, as Vice President, Clinical Development. Dr. Raymond, who will report to Joe Sardano, Sensus CEO, […]

Read More

Sensus Healthcare Appoints Rita Gable as Vice President of Sales – Oncology

BOCA RATON, Fla., May 1, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced this morning the appointment of Rita Gable as Vice President of Sales – Oncology, effective immediately. Ms. Gable has 15 years of sales experience, specializing in […]

Read More

Sensus Healthcare to Host First Quarter 2018 Financial Results and Business Update Conference Call on May 3, 2018

BOCA RATON, Fla., April 26, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management will hold a conference call on Thursday, May 3, 2018 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter of 2018. […]

Read More

Sensus Healthcare Expands International Business to Meet Rising Patient Demand for Non-Invasive Skin Cancer and Keloid Treatments

BOCA RATON, Fla., April 19, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today that the Company is expanding its global business with SRT to meet growing demand for non-invasive, highly effective skin cancer and keloid treatments. Rick […]

Read More

Sensus Healthcare to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium

BOCA RATON, Fla. (March 8, 2018) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), and multi-platform state of the art aesthetic lasers, today announced the Company will present at the B. Riley FBR Inaugural China Healthcare Investing […]

Read More

Sensus Healthcare Launches New Line of Laser Systems to Provide Patients with Full Spectrum of Clinical and Aesthetic Dermatological Solutions

BOCA RATON, Fla., March 5, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), announced today that the Company has launched Sensus Laser Systems, a unique multi-platform line of high-quality, cost-effective dermatological lasers to compliment Sensus’ existing SRT system. Sensus Laser Systems includes capabilities for hair and tattoo removal, acne lesion correction, skin rejuvenation and pigmentation/large pore treatment. Read […]

Read More

Sensus Healthcare Opens Tel Aviv Office to Expand Footprint in Israel, the Middle East & Europe

BOCA RATON, Fla., Feb. 7, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), announced today that the Company is opening a new office in Tel Aviv to deepen its presence in Israel, the Middle East and Europe—while continuing to bring Sensus’ innovative SRT treatment to patients all over the world who are afflicted with both non-melanoma skin cancers and keloids. Read the […]

Read More

Sensus Healthcare Launches Collaboration with BirchBioMed

Sensus Healthcare Launches Collaboration with BirchBioMed to Treat and Prevent Scarring for Keloids Patients Around the World On February 5th, 2018, Sensus Healthcare announced their collaboration with BirchBioMed, Inc. BirchBioMed, Inc., is a biomedical company focused on anti-scarring medications, to treat and prevent scarring more effectively for patients with keloids. Read the full press release […]

Read More

Sensus Healthcare Announces Clearance to Market the SRT-100™ in Mexico

BOCA RATON, Fla. (October 31, 2017) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that the SRT-100™ is now cleared for sale in Mexico. The system is approved for the treatment of non-melanoma skin cancer and […]

Read More

Stratpharma AG & Sensus Healthcare Announce Strategic Collaboration for Transformative Superficial Radiation Therapy & Post-Treatment Care

Collaboration Brings Sensus Healthcare’s SRT Technology and Stratpharma’s Wound Care Medical Devices Together to Advance Radiation Patient Outcomes San Diego, Calif. (October 23, 2017) – Stratpharma Inc. USA, a U.S. subsidiary of Stratpharma AG, the Swiss company that specializes in innovative film-forming full-contact topical medical products to improve medical and aesthetic outcomes in post-procedure care […]

Read More

Sensus Healthcare Details Abstract on Keloid Treatment with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting

BOCA RATON, Fla. (October 9, 2017) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radiation Therapy (SRT), announced today that an abstract was presented at the American Society for Dermatologic Surgery (ASDS) Annual Meeting, which took place on Oct. 5-8 in […]

Read More

American Society for Dermatologic Surgery Annual Meeting to Include Presentation on the Effectiveness of SRT

BOCA RATON, Fla., October 2, 2017 – Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions, such as keloids with Superficial Radiation Therapy (SRT), announced today that the 2017 American Society for Dermatologic Surgery (ASDS) Annual Meeting in Chicago will include a […]

Read More

Sensus Healthcare Installs Second Next-Generation SRT-100 Vision System in Israel to Treat Skin Cancer and Keloids

New SRT-100 Vision Now at Beilinson Hospital / Rabin Media Center in Petah Tikva BOCA RATON, Fla. – September 20, 2017 – Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancer and other skin conditions, such as keloids, with superficial radiotherapy (SRT), today announced that the Company […]

Read More

Sensus Healthcare Receives Regulatory Approval to Sell the SRT-100™ in China for the Treatment and Prevention of Keloids

BOCA RATON, Fla. (July 26, 2017) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that the SRT-100™ has been cleared by the China Food and Drug Administration (CFDA) to treat and prevent keloids. China accounts for […]

Read More

Sensus Healthcare to Exhibit at the 2017 American Association of Physicists in Medicine Annual Meeting

BOCA RATON, Fla. – July 19, 2017 – Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions, such as keloids with Superficial Radiation Therapy (SRT), announced that the Company will be exhibiting at the 2017 American Association of Physicists in Medicine (AAPM) […]

Read More

Sensus Healthcare Awarded 2017 Technology Leader of the Year for Disruptive Technology from Greater Miami Chamber of Commerce

BOCA RATON, Fla., May 24, 2017 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions, such as keloids with Superficial Radiotherapy (SRT), has been awarded the 2017 Technology Leader of the Year for the Disruptive Technology category by The Greater Miami […]

Read More

Sensus Healthcare to Host First Quarter 2017 Financial Results and Business Update Conference Call on May 4, 2017

BOCA RATON, Fla., April 27, 2017 /PRNewswire/ — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announced today that management will hold a conference call beginning at 4:30 p.m. Eastern Time on Thursday, May 4, 2017 to discuss the […]

Read More

Sensus Healthcare to Participate in 2017 South Beach Symposium on February 9 – 12 in Miami

Joe Sardano, Sensus Healthcare CEO, to Participate in CEO Forum on February 11 Sensus Healthcare Medical Advisory Board Members to Host SRT Workshops on February 9 BOCA RATON, Fla., Feb. 7, 2017 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, […]

Read More

Sensus Healthcare, Inc. Receives the Frost & Sullivan 2016 Global Non-melanoma Skin Cancer Therapy Technology Leadership Award

September 7, 2016 Boca Raton, FL Sensus Healthcare, Inc. Receives the Frost & Sullivan 2016 Global Non-melanoma Skin Cancer Therapy Technology Leadership Award – Sensus Credited with Advancing Superficial Radiation Therapy as Viable Treatment Option for NMSC – Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers […]

Read More

Sensus Healthcare (SRTSU) To Sponsor First International Keloid Symposium On September 8 And 9 In New York

August 31, 2016 Boca Raton, FL Sensus Healthcare (SRTSU) To Sponsor First International Keloid Symposium On September 8 And 9 In New York Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy (SRT), today announced that […]

Read More

Sensus Healthcare, Inc. Appoints Dr. Darrell Rigel to its Board of Directors

June 13, 2016 Boca Raton, FL Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced the appointment of Darrell S. Rigel, MD, MS, to its Board of Directors.  Dr. Rigel is a Clinical Professor […]

Read More

KCSA Strategic Communications Advises Sensus Healthcare on Successful IPO: Rings the NASDAQ Bell Along Side Sensus Management

June 10, 2016 New York, NY KCSA Strategic Communications, a leading provider of integrated communications solutions announced its participation in the opening bell ringing ceremony at the Nasdaq MarketSite for its client, Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as […]

Read More

Sensus Healthcare, Inc. Prices Initial Public Offering

June 02, 2016 Boca Raton, FL Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced the pricing of its initial public offering of 2,000,000 units at a public offering price of $5.50 per unit, […]

Read More

Sensus Healthcare Receives FDA 510k Clearance for Next Generation Image Guided Superficial Radiotherapy SRT-100 Vision(TM)

October 19, 2015 San Antonio, TX (GLOBE NEWSWIRE) Sensus Healthcare, the market leader in superficial radiation therapy treatment of skin cancer and keloids, announces FDA clearance for the next generation SRT-100 Vision™ system at the American Society for Radiation Oncology (ASTRO) 2015 exhibition in San Antonio, TX. The next generation SRT-100 Vision™ features unique integration […]

Read More

Advanced Dermatology and Cosmetic Surgery Partners with Sensus Healthcare

August 07, 2015 Boca Raton, FL Advanced Dermatology and Cosmetic Surgery, the nation’s largest dermatology practice, partners with medical device company to help treat non-melanoma skin cancers and keloids. ADCS Clinics (“ADCS”) announced it has partnered with Sensus Healthcare LLC (Boca Raton, FL) to treat patients with non-melanoma skin cancers and keloids in a non-invasive and […]

Read More

FDA-Approved SRT-100™ Revolutionizes Keloid Scar Removal

July 27, 2013 New York, NY The Food and Drug Administration (FDA) has recently gave Sensus Healthcare the clearance to use its revolutionary product, the SRT-100, the green signal to treat hypertrophic scars and keloid scars, or simply referred to as keloids. Sensus Healthcare claims that this technological advance in treating keloids will provide patients […]

Read More

Sensus Healthcare Introduces High-Frequency Ultrasound Image Guidance Technology to Its Superficial Radiotherapy Device

July 1, 2015 Boca Raton, Florida Sensus Healthcare, a manufacturer and marketer of medical devices that incorporate superficial radiation therapy (SRT) for noninvasive treatment of non-melanoma skin cancers and keloids, will debut its SRT-100 Vision System™ at the American Association of Physicists in Medicine (AAPM) exhibition in Anaheim, Calif. The upcoming meeting brings together leading […]

Read More

ACOS Holds First Meeting on Best Practices in Superficial Radiation Therapy for Non-Melanoma Skin Cancers

June 10, 2015 Boca Raton, FL Leading Dermatologist Dr. Clay J. Cockerell Hosts Educational Event Chaired by Dr. Mark Nestor, President of ACOS The American Cutaneous Oncology Society (ACOS) brought together nearly 100 dermatologists to share the science and best practices of providing Superficial Radiation Therapy (SRT) to patients with non-melanoma skin cancer (NMSC). The first annual physicians meeting, […]

Read More

Sensus Healthcare Receives FDA Clearance to Treat Keloids with the SRT-100™

May 24, 2013 Boca Raton, FL Sensus Healthcare is pleased to announce that it has received clearance from the U.S. Food and Drug Administration to treat Keloids with the SRT-100™. The SRT-100™ is the leading alternative to surgery in treating Non Melanoma Skin Cancer and now is approved to treat Keloids caused by surgery or […]

Read More

Sensus Healthcare Teams Up with Jeffrey Klein MD and Dermatology Associates of Orange County to Offer Non-Invasive Procedure for Non-Melanoma Skin Cancers

May 19, 2015 Boca Raton, FL Sensus Healthcare, a manufacturer and marketer of medical devices that incorporate superficial radiation therapy (SRT) for noninvasive treatment of non-melanoma skin cancers and keloids, proudly announces a new physician-user to its roster of leading Dermatologists and Radiation Oncologists. World- renowned expert in skin cancer, general and cosmetic dermatology, Jeffrey Klein, MD, […]

Read More

Sensus Healthcare Presented with Prestigious New Product Innovation Leadership Award for Non-Melanoma Skin Cancer Therapy

March 21, 2014 Boca Raton, Florida Frost & Sullivan has recognized Sensus Healthcare with the 2014 North American award for New Product Innovation Leadership. Each year, Frost & Sullivan presents this award to the company that has developed an innovative element in a product by leveraging leading-edge technologies. The award recognizes the value added features/benefits […]

Read More

Sensus Healthcare Announces its Exhibitor Attendance at the 71st Annual American Academy of Dermatology Meeting

February 22, 2013 Boca Raton, FL Sensus Healthcare is proud to announce their exhibitor participation in the 71st Annual American Academy of Dermatology Meeting in Miami Beach, FL on March 1-5, 2013. Visit booth #2701to learn more about the advanced SRT-100™ superficial radiotherapy platform, featuring SharpBeam™, it’s unique characteristics and advantages over other NMSC treatment […]

Read More

Sensus Healthcare Receives Medical Device License from Health Canada

November 15, 2012 Boca Raton, FL Sensus Healthcare is proud to announce that it has received a Medical Device License from Health Canada, permitting the company to commence selling its advanced SRT-100™ in Canada. The SRT-100™ is a state-of-the-art therapy device for Non-Melanoma Skin Cancer. The SRT-100™ provides patients with a virtually pain-free, non-invasive treatment option, while […]

Read More

Sensus Healthcare Announces its Exhibitor Attendance at the 54th Annual ASTRO Meeting

September 28, 2012 Boca Raton, FL Sensus Healthcare is pleased to announce its exhibitor participation in the 54th Annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Boston, MA on October 28 – 31, 2012. Visit Booth #9054 to learn more about the advanced SRT-100™ superficial radiotherapy platform, it’s unique characteristics […]

Read More

Sensus Healthcare Announces the Publication of a Comprehensive Study on Treating Non-Melanoma Skin Cancer in JAAD

September 28, 2012 Boca Raton, FL Sensus Healthcare is pleased to announce the acceptance and publication of the most comprehensive study to date on treating Non Melanoma Skin Cancer (NMSC) with superficial radiotherapy (SRT) in the Journal of the American Academy of Dermatology (JAAD). The comprehensive study, which examined 1,715 NMSC lesions in 1,149 patients, […]

Read More

Sensus Healthcare Announces Sale of 100th Skin Cancer Treatment Device

September 26, 2012 Boca Raton, FL Sensus Healthcare is proud to announce a major milestone in selling its 100th SRT-100™ advanced superficial radiotherapy (SRT) system. The SRT-100™ is a global success for treating Non Melanoma Skin Cancer on all major continents. The SRT-100™ provides patients with a virtually pain-free non-invasive treatment option, while achieving excellent […]

Read More

Sensus Healthcare Announces Attendance at the 2012 Fall Clinical Dermatology Conference

September 24, 2012 Boca Raton, FL Sensus Healthcare is pleased to announce its attendance at the 2012 Fall Clinical Dermatology Conference at The Encore Hotel, Las Vegas, NV on October 4 – 7, 2012. Sensus will be demonstrating its advanced superficial radiotherapy platform, the SRT-100™ for the non- invasive treatment of skin cancer. Sensus will […]

Read More

Sensus Healthcare Installs an SRT-100™ at Froedtert & The Medical College of Wisconsin Cancer Center and Commences Collaborative Research Relationship

September 24, 2012 Boca Raton, FL Sensus Healthcare is pleased to announce that Froedtert & The Medical College of Wisconsin Cancer Center has chosen the SRT-100™ advanced superficial radiotherapy platform (SRT) as the latest addition to its comprehensive radiotherapy solutions for cancer. Froedtert & The Medical College Cancer Center is the first cancer center in […]

Read More

Sensus Healthcare Receives SFDA Approval to Sell the SRT-100™ in China

September 19, 2012 Boca Raton, FL Sensus Healthcare and Megatop MTC are pleased to announce the SFDA approval of the SRT-100™ advanced superficial radiotherapy platform to be sold in China. This approval allows Megatop MTC to begin their sales and marketing initiatives in China immediately. Megatop has already ordered 9 systems to be delivered in […]

Read More

Sensus Healthcare Announces the Sale of its SRT-100™ Superficial Radiotherapy Unit to Hong Kong Sanatorium & Hospital in Hong Kong

August 6, 2012 Boca Raton, FL Sensus Healthcare, the global leader in superficial radiotherapy for non-melanoma skin cancers, announces the purchase of their SRT-100™ therapy system by Hong Kong Sanatorium & Hospital of Hong Kong through their Chinese distributor, Megatop Medical Technologies Co., Ltd. Hong Kong Sanatorium & Hospital is one of the most prestigious […]

Read More

Sensus Healthcare Announces an Alliance with Mission Search Corporation to provide Commissioning Services for the Sensus SRT-100™

July 30, 2012 Boca Raton, Florida Sensus Healthcare, a global leader in superficial radiotherapy for non-melanoma skin cancers, is joining forces with Mission Search Corporation, a Tampa, Florida based healthcare search and staffing organization to provide commissioning services to Sensus’ clientele. Sensus Healthcare is taking new aim at non-melanoma skin cancer by focusing on the […]

Read More

Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center Announce the Formation of the SRT University™ Comprehensive Education Series for Practitioners, Healthcare Professionals, and Patients

May 18, 2012 Boca Raton, FL and Texas Dermatology Associates at Baylor University Medical Center of Dallas, TX are proud to announce the establishment of the SRT University™ Comprehensive Education Series for practitioners, healthcare professionals, and patients. SRT University™ will offer multi-tiered education and training curriculums for the provider and patient populations, thus increasing the […]

Read More

Sensus Healthcare and Megatop MTC announce their first sale of the SRT-100™ Superficial Radiation Therapy system to the Prince of Wales Hospital in Hong Kong

July 27, 2011 Boca Raton, FL Sensus Healthcare is pleased to announce that the Prince of Wales Hospital in Hong Kong has become the first healthcare facility in the country to purchase and deploy an SRT-100™ non-invasive skin cancer treatment system. The SRT-100™ will provide the local patient community with the most effective, non-surgical, and pain […]

Read More

Sensus Healthcare Announces Its Exhibitor Participation at the 86th National Congress of SIDeMaST in Verona, Italy

May 23, 2011 Boca Raton, FL Sensus Healthcare is pleased to have exhibited at the 86th National Congress of SIDeMaST (The Italian Society of Dermatology) in Verona, Italy, May 18th – May 21st. Sensus Healthcare featured its SRT-100™ non-surgical, superficial photon therapy system for non-melanoma skin cancers. This year’s event was considered an important national […]

Read More

Sensus Healthcare Has Obtained ISO 13485:2003 Certification & CE Mark

May 23, 2011 Boca Raton, FL Sensus Healthcare is pleased to have obtained ISO 13485:2003 certification and CE (Conformité Européenne, which is French for “European Conformity”) mark. As regulatory requirements, standards, and high customer expectations continue to set the bar for medical product manufacturers and their suppliers, Sensus takes pride in its compliance and continued […]

Read More

Sensus Healthcare Announces Medical Director and Medical Advisory Board

February 14, 2011 Boca Raton, FL Sensus Healthcare has announced Dr. Armand B. Cognetta as its Medical Director and Chair of the Medical Advisory Board. Dr. Cognetta will provide clinical guidance and patient advocacy in the ongoing development of the Company’s leading Superficial Radiotherapy product platform, the SRT-100™, and also lead the Company’s multi-disciplinary Medical […]

Read More

Sensus Healthcare Announces The Formation of a Medical Advisory Board

February 14, 2011 Boca Raton, FL Sensus Healthcare has announced the formation of a Medical Advisory Board (MAB). Accepting to Chair this Board as Medical Director is Dr. Armand B. Cognetta, distinguished Dermatologist and founder of Dermatology Associates of Tallahassee, Florida. Dr. Cognetta is recognized as a leader and innovator in his field. Dr. Cognetta […]

Read More

Sensus Healthcare Announces the World Premiere of its Electronic Healthcare Records (EHR) System – Astrum™ EHR

February 1, 2011 Boca Raton, FL Sensus Healthcare has announced its new all-inclusive Electronic Health Records (EHR) system – Astrum™ EHR. Astrum™ EHR is offering a total solution without compromises that includes EHR/EMR, Practice Management (PM), Patient Healthcare Records (PHR), e-Prescription, powerful merchant engines, MU/PQRI/HIPAA full compliance, and many other seamlessly-integrated features that provide unparalleled, […]

Read More

Sensus Healthcare Announces its Exhibitor Attendance at the 69th Annual American Academy of Dermatology Meeting

January 24, 2011 Boca Raton, FL Sensus Healthcare is proud to announce their exhibitor participation in the 69th Annual American Academy of Dermatology Meeting in New Orleans, LA on February 4-8, 2011. Visit booth #3921 to learn about the SRT-100™ low-dose non-invasive superficial radiotherapy (SRT) non-melanoma skin cancer therapy product line, the Sensus Skin Solutions™ professional […]

Read More

Sensus Healthcare Announces Strategic Partnership with Flagship Solutions Group

January 7, 2011 Boca Raton, FL Sensus Healthcare has established a strategic partnership with Flagship Solutions Group in order to merge joint interests in medical and IT solutions. Sensus Healthcare is teaming with Flagship SG in order to provide world-class IBM products and services to its current and future served markets. Through this strategic partnership […]

Read More

Sensus Healthcare unveils streamlined design for signature skin cancer treatment system at world’s largest radiation oncology conference – ASTRO

November 2, 2010 San Diego, CA A new technology company committed to providing a viable treatment option for millions of skin cancer sufferers unveiled a re-design of its signature system this week at the American Society for Radiation Oncology (ASTRO) Annual Conference. ASTRO is the largest radiation oncology society in the world, with more than […]

Read More

Sensus Healthcare Sells First SRT-100™ in Thailand

October 7, 2010 Boca Raton, FL Asoke Skin Hospital of Bangkok has become the first healthcare facility in Thailand to successfully complete the installation and deployment of the SRT-100TM non-invasive skin cancer treatment system, officials with Sensus Healthcare announced today. Thailand’s first and only specialized dermatologic and plastic surgery facility, Asoke Skin Hospital is a […]

Read More

The Benefits of SRT

Along with eliminating the risks for post-surgical infections and complications, the SRT-100™ provides patients and physicians with a safe and effective treatment option that offers many benefits, including:

  1. 95%+ cure rates that rival surgery
  2. No anesthesia, cutting, bleeding, stitching or pain
  3. No downtime or lifestyle restrictions
  4. Super cosmesis, no unsightly scarring
  5. No need for post-treatment reconstructive surgeries